Continuing the Euroclone story

When I first considered selling my company, I thought, “Let us see,” and I committed to staying for a couple of years. What surprised me was how much I enjoyed it. In fact, when I was told, “If you want to stay, you can stay,” my answer was simple: “Yes, I want to stay.” I still enjoy it every day.

For me, joining AddLife wasn’t about stepping away from what I had built, but about finding new opportunities to continue the journey I started. Being part of a larger group means there’s so much more we can do together. With the support of AddLife Management and the network of other companies, I’m able to explore new areas that contribute to the growth of both Euroclone and the group as a whole.

My passion remains as strong as ever. As an entrepreneur, my dream has always been to bring innovative products to the Italian scientific community as quickly as possible, providing researchers with the best tools to advance their work. Our motto was “Serve Science through Innovation,” and that’s still what drives us today.

What makes AddLife unique is how they combine the resources, network, and expertise of a large company with the flexibility, personality, and efficiency of an entrepreneur. The decentralised model works—it allows us to stay agile and adapt to market changes, while maintaining the strong relationships we’ve built with both the scientific community and our suppliers.

Since joining AddLife, our strategy has continued to grow stronger. We’re now able to pursue new ventures and technologies, especially in fast-growing areas like next-generation sequencing, single-cell analysis, and spatial biology. With AddLife, we’re not just continuing what we started; we’re building something even greater, together.

The future is bright, and I’m proud to be part of the AddLife family.

Franco Aiolfi, MD and founder of Euroclone

Read more about Euroclone here: https://www.euroclonegroup.it/